1.0ElmediXhttps://www.elmedix.com/en/rich600338<blockquote class="wp-embedded-content" data-secret="6eQkOFLZJv"><a href="https://www.elmedix.com/en/margaret-tempero/">Margaret Tempero</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.elmedix.com/en/margaret-tempero/embed/#?secret=6eQkOFLZJv" width="600" height="338" title="“Margaret Tempero” — ElmediX" data-secret="6eQkOFLZJv" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.elmedix.com/wp-includes/js/wp-embed.min.js </script> Margaret Tempero, MD, is a professor of medicine, director of the UCSF Pancreas Center, and editor-in-chief of JNCCN. Her research career focuses on pancreatic ductal adenocarcinoma, particularly in the area of experimental therapies. Dr. Tempero has served on the ASCO board and has acted as its president. She is currently a member of the board of the ASCO Conquer Cancer Foundation.https://www.elmedix.com/wp-content/uploads/2025/02/download.jpg